| Recent advancements in the treatment of resistant hypertension. | |
| | |
MedLine Citation:
|
PMID: 22314116 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The 2008 scientific statement from the American Heart Association defined resistant hypertension as blood pressure remaining above goal (< 140/90 mm Hg for the general population and < 130/80 mm Hg for patients with diabetes or renal disease) despite the concurrent use of optimal doses of 3 antihypertensive agents of different classes, ideally including a diuretic. Since then, there has been increasing recognition and characterization of patients with resistant hypertension and development of treatment strategies to treat this high-risk population. The role of aldosterone in resistant hypertension has gained increasing recognition. In particular, there has been development of a strong body of evidence for the use of spironolactone as a highly effective antihypertensive agent. Furthermore, there is increasing evidence to link aldosterone with both resistant hypertension and obstructive sleep apnea, with preliminary studies suggesting that aldosterone antagonists may potentially be effective in treating both conditions. Finally, recent work has directed increased attention toward novel invasive strategies for the treatment of resistant hypertension, specifically baroreflex activation therapy with carotid stimulation and percutaneous renal artery denervation. Initial randomized controlled trials have shown that both of these methods may be used to safely lower blood pressure, thereby providing exciting and promising new tools in the armamentarium of options to treat resistant hypertension. |
| | |
Authors:
|
Donald Clark; Jason L Guichard; David A Calhoun; Mustafa I Ahmed |
Related Documents
:
|
22533546 - Three-year safety and effectiveness of fixed-dose losartan/hydrochlorothiazide combinat... 6539236 - Effect of verapamil on reperfusion damage and calcium paradox in isolated rat heart. 22473256 - Heart lung interactions during mechanical ventilation. 15490226 - In vivo heat shock preconditioning mitigates calcium overload during ischaemia/reperfus... 2831596 - Triiodothyronine increases survival in canine hemorrhagic shock. 8470606 - John caffey award. colonic perforation by air and liquid enemas: comparison study in yo... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Postgraduate medicine Volume: 124 ISSN: 1941-9260 ISO Abbreviation: Postgrad Med Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-02-08 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0401147 Medline TA: Postgrad Med Country: United States |
Other Details:
|
Languages: eng Pagination: 67-73 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine, Division of Cardiovascular Disease, Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chlorthalidone: the forgotten diuretic.
Next Document: Evaluation and pharmacologic approach to patients with resistant hypertension.